热门资讯> 正文

资产负债表改善后，BioCardia重新获得纳斯达克合规性;股价上涨

2025-10-02 20:23

BioCardia (NASDAQ:BCDA) has regained compliance with Nasdaq listing requirements.
On October 1, 2025, Nasdaq confirmed BioCardia now meets the Equity Rule.
Compliance follows efforts to strengthen the company’s balance sheet, including raising new capital.
BCDA shares up 7% premarket on Thursday.
Source: Press release

More on BioCardia

BioCardia, Inc. (BCDA) Q2 2025 Earnings Call Transcript
BioCardia announces pricing of up to $12M public offering
BioCardia outlines regulatory milestones and targets FDA and PMDA submissions for CardiAMP and Helix in Q4 2025
Seeking Alpha’s Quant Rating on BioCardia
Historical earnings data for BioCardia

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。